Baxter International Inc (NYSE:BAX) Position Increased by IBM Retirement Fund

IBM Retirement Fund raised its holdings in shares of Baxter International Inc (NYSE:BAX) by 4.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,915 shares of the medical instruments supplier’s stock after purchasing an additional 494 shares during the period. IBM Retirement Fund’s holdings in Baxter International were worth $1,026,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. FSA Wealth Management LLC bought a new position in shares of Baxter International during the fourth quarter worth about $25,000. Harwood Advisory Group LLC bought a new position in shares of Baxter International during the first quarter worth about $32,000. grace capital bought a new position in shares of Baxter International during the fourth quarter worth about $33,000. Prestige Wealth Management Group LLC grew its position in shares of Baxter International by 14,066.7% during the first quarter. Prestige Wealth Management Group LLC now owns 425 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 422 shares during the last quarter. Finally, BDO Wealth Advisors LLC bought a new position in shares of Baxter International during the first quarter worth about $41,000. Institutional investors and hedge funds own 83.72% of the company’s stock.

A number of equities analysts recently issued reports on the stock. Deutsche Bank decreased their target price on shares of Baxter International from $109.00 to $99.00 and set a “buy” rating for the company in a research report on Wednesday, March 18th. Wells Fargo & Co increased their target price on shares of Baxter International from $92.00 to $104.00 and gave the company an “overweight” rating in a research report on Monday, April 20th. Barclays reiterated a “hold” rating and issued a $84.00 target price on shares of Baxter International in a research report on Tuesday, April 14th. UBS Group increased their target price on shares of Baxter International from $95.00 to $103.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Finally, TheStreet upgraded shares of Baxter International from a “c+” rating to a “b+” rating in a research report on Thursday, April 30th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have assigned a buy rating to the company. Baxter International presently has an average rating of “Buy” and a consensus price target of $96.43.

In other Baxter International news, SVP Giuseppe Accogli sold 72,341 shares of the company’s stock in a transaction dated Friday, June 19th. The shares were sold at an average price of $85.00, for a total transaction of $6,148,985.00. Following the completion of the sale, the senior vice president now directly owns 76,473 shares of the company’s stock, valued at $6,500,205. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Jeanne K. Mason sold 47,146 shares of the company’s stock in a transaction dated Monday, April 27th. The shares were sold at an average price of $93.13, for a total transaction of $4,390,706.98. Following the sale, the senior vice president now directly owns 163,485 shares of the company’s stock, valued at $15,225,358.05. The disclosure for this sale can be found here. Insiders have sold 124,729 shares of company stock valued at $11,004,639 over the last ninety days. Insiders own 0.13% of the company’s stock.

BAX stock opened at $84.18 on Thursday. The company has a current ratio of 2.74, a quick ratio of 2.19 and a debt-to-equity ratio of 0.84. Baxter International Inc has a one year low of $69.10 and a one year high of $95.19. The firm has a market capitalization of $43.37 billion, a PE ratio of 25.43, a P/E/G ratio of 2.53 and a beta of 0.84. The firm has a 50-day moving average of $86.45 and a two-hundred day moving average of $86.64.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.82 EPS for the quarter, beating analysts’ consensus estimates of $0.73 by $0.09. Baxter International had a net margin of 8.85% and a return on equity of 22.70%. The company had revenue of $2.80 billion during the quarter, compared to analyst estimates of $2.74 billion. During the same period in the prior year, the firm earned $0.76 earnings per share. The business’s quarterly revenue was up 6.2% on a year-over-year basis. On average, equities research analysts anticipate that Baxter International Inc will post 3.29 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 1st. Shareholders of record on Friday, June 5th were paid a dividend of $0.245 per share. The ex-dividend date of this dividend was Thursday, June 4th. This is a positive change from Baxter International’s previous quarterly dividend of $0.22. This represents a $0.98 dividend on an annualized basis and a yield of 1.16%. Baxter International’s dividend payout ratio is currently 29.61%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Featured Story: Penny Stocks, Risk and Reward Factors

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.